Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Neuropharmacology. 2012 Sep 13;65:134–142. doi: 10.1016/j.neuropharm.2012.09.004

Figure 4. Decreased rates of vesicle release failures during WD.

Figure 4

A) Representative traces showing mean Sr2+ dependent EPSC responses and non release event failures (Black traces). Representative raw data (20 sweeps) from exemplar cell (Gray traces). * indicates truncated stimulus artifact. B) WD decreases release failure rates [CON (8); WD (7); t = 2.492, df = 13, * = p < 0.05]. C) Stimulation intensities did not differ between treatment conditions [CON (8); WD (7); t = 0.47 df = 13, p > 0.05]. D) Non-failure EPSC amplitude events do not differ with treatment [CON (8), WD (7); t =0.824, df = 13, p > 0.05].